These gain-of-function somatic aberrations in the ligand-binding domain of gp130/IL6ST caused changes in intracellular distribution of the receptor and constitutive ligand-independent activation of STAT3 [259,260], exemplifying a novel mechanism for overactivation of pro-tumourigenic signals observed in many tumours. The gene discussed is IL6ST; the disease is neoplasm.